Status:
UNKNOWN
Cardio-Cerebrovascular Co-Prevention and Co-Management Based on Internet+
Lead Sponsor:
Nanfang Hospital, Southern Medical University
Collaborating Sponsors:
The Seventh Affiliated Hospital, Southern Medical University
Conditions:
Cardiovascular Diseases
Myocardial Ischemia
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Coronary heart disease and stroke are belong to the atherosclerotic vascular disease (ASCVD). When both occur at the same time, the mortality rate is 19%-37%. Especially when ischemic stroke occurs in...
Detailed Description
The open label, cluster randomized, controlled clinical trial to evaluate the efficacy of smartphone App in the management of the high-risk population of cardio-cerebrovascular diseases. The trial wit...
Eligibility Criteria
Inclusion
- Family physician teams:
- The number of residents served is more than 30,000;
- The proportion of high-risk population of cardio-cerebrovascular diseases is more than 8%;
- manage the health records of residents;
- have a health examination for the residents once a year;
- Family doctors have smartphones.
- Participants:
- Aged ≥18 years;
- Meet any of the following indicators:
- 1\) LDL-C\>4.9mmol/L or TC\>7.2mmol/L; 2) Diabetic patients (age \>40 years old): 1.8mmol/L≤LDL-C\<4.9mmol/L（or）3.1mmol/L≤TC\<7.2mmol/L; 3) The predicted risks measured by China-PAR model of ≥10%; 4) Patients with predicted risks measured by China-PAR model of ≥5% and \<10%, and meet with two or more risk factors as following:
- Systolic Blood Pressure ≥ 160mmHg or Diastolic Blood Pressure ≥ 100mmHg,
- BMI≥28kg/m2,
- Non- HDL-C≥5.2mmol/L,
- Smoking,
- HDL-C\<1.0mmol/L. (3) Local permanent residents (more than 5 years); (4) No severe physical disability, clear consciousness and normal communication; (5) The participants in the intervention group or their families have smartphones; (6) Disease and death are under the management of the local health department; (7) Sign the informed consent form voluntarily.
Exclusion
- Family physician teams:
- The establishment of residents' health records is incomplete;
- The main population served are temporary residents and floating population.
- Participants:
- Temporary residents and floating population;
- Those who have serious health conditions and are unable to participate in this study;
- Those who are unwilling to accept the follow-up inspection;
- According to the judgment of the researchers, it is not suitable to participate.
Key Trial Info
Start Date :
May 20 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2023
Estimated Enrollment :
8840 Patients enrolled
Trial Details
Trial ID
NCT04409210
Start Date
May 20 2020
End Date
December 31 2023
Last Update
June 1 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nanfang Hospital, Southern Medical University
Guangzhou, Guangdong, China, 510515